ESC 365 - Proteogenomic analysis in population biobanks identifies new therapeutic targets across heart failure subtypes

ESC Premium Access

Proteogenomic analysis in population biobanks identifies new therapeutic targets across heart failure subtypes

Session: Genetics: new findings across the spectrum of cardiovascular disease

Topic: Drugs, Drug Targets

Speaker: Doctor A. Henry (London, GB)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Albert Henry

University College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Does PhenoAge acceleration impact adverse outcomes following major surgery (rehospitalization or death)? A genome-wide association study and mendelian randomisation

Speaker: Doctor M. Raja (Leicester, GB)

A Genome-Wide Association Study (GWAS) of Takotsubo syndrome

Speaker: Doctor H. Hakansson (Stockholm, SE)

Pathogenic cardiomyopathy gene variants inform prognosis in atrial fibrillation: results from exome sequencing in over 17,000 patients in TIMI trials

Speaker: Mr S. Jurgens (Cambridge, US)

Exome sequencing identifies a novel FBN1 variant in a Chinese family with Marfan syndrome that includes aberrant right subclavian artery

Speaker: Doctor S. Huang (Guangzhou, CN)

Reinterpretation of genetic testing for Cardiomyopathies: Less is more

Speaker: Doctor V. Novelli (Monzino, IT)

Access the full session

Genetics: new findings across the spectrum of cardiovascular disease

Speakers: Doctor A. Henry, Doctor M. Raja, Doctor H. Hakansson, Mr S. Jurgens, Doctor S. Huang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources